Diagnostics buoyant in South Korea
This article was originally published in Clinica
South Korea's diagnostics industry is continuing to go from strength to strength. Diagnostics production totalled Won50.6 billion ($57 million) in 1996, up from Won31.1 billion in 1994. Pharma Koreana predicts that the market will hit Won200 billion by 2000.
You may also be interested in...
Medical products that do not fully comply with Canadian requirements but are manufactured according to comparable standards are being allowed into the country to deal with COVID-19-related shortages.
A randomized COVID-19 study spanning the whole of the UK could help to bolster the UK’s reputation as a location for future clinical trials. It is also being seen partly as the result of the UK regulator's "decisive action" in fast-tracking trials for potential COVID-19 therapies.
Manufacturers of endoscopic equipment, biofeedback devices and thermometers were among those cited for regulatory violations in US FDA warning letters this week. A total of four device-related enforcement missives were released by the agency.